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Induction of Activity-Dependent LTD Requires Muscarinic
Receptor Activation in Medial Prefrontal Cortex
Douglas A. Caruana, E. CleaWarburton, and Zafar I. Bashir
MRC Centre for Synaptic Plasticity, School of Physiology and Pharmacology, University of Bristol, Bristol BS8 1TD, United Kingdom
Themedial prefrontal cortex (mPFC) forms part of a neural circuit involved in the formation of lasting associations between objects and
places. Cholinergic inputs from the basal forebrain innervate themPFC andmaymodulate synaptic processes required for the formation
of object-in-placememories. To investigate whether acetylcholine regulates synaptic function in the ratmPFC, whole-cell voltage-clamp
recordings were made from pyramidal neurons in layer V. Bath application of the cholinergic agonist carbachol caused a potent and
long-term depression (LTD) of synaptic responses that was blocked by the muscarinic receptor antagonist scopolamine and was mim-
icked, in part, by theM1 receptor agonistsMcN-A-343 or AF102B. Furthermore, inhibition of PKC blocked carbachol-mediated LTD.We
next determined the requirements for activity-dependent LTD in the prefrontal cortex. Synaptic stimulation that was subthreshold for
producing LTD did, however, result in LTD when acetylcholine levels were enhanced by inhibition of acetylcholinesterase or when
delivered in the presence of theM1-selective positive allostericmodulator BQCA. Increasing the levels of synaptic stimulation resulted in
M1 receptor-dependent LTDwithout the need for pharmacologicalmanipulation of acetylcholine levels. These results show that synaptic
stimulation of muscarinic receptors alone can be critical for plastic changes in excitatory synaptic transmission in the mPFC. In turn,
these muscarinic mediated events may be important in the formation of object-in-place memories. A loss of basal forebrain cholinergic
neurons is a classic hallmark of Alzheimer’s dementia and our results provide a potential explanation for the loss of memory associated
with the disease.
Introduction
Acetylcholine is important for different forms of learning, mem-
ory, and experience-dependent plasticity. Lesions of cholinergic
nuclei (Aigner et al., 1991; Everitt andRobbins, 1997), disruption
of cholinergic transmission (Ebert and Kirch, 1998), or genetic
deletion of acetylcholine receptors (Anagnostaras et al., 2003)
impairs cognitive function, although the reasons for the deficits
remain controversial. We have shown that object recognition
memory and long-term depression (LTD) in perirhinal cortex
rely on activation of muscarinic acetylcholine receptors (mAChRs)
(Massey et al., 2001; Warburton et al., 2003), suggesting that
muscarinic-mediated synaptic plasticity may be important for
recognition memory. Object-in-place memory is a form of asso-
ciative memory that depends critically on perirhinal cortex and
medial prefrontal cortex (mPFC) (Kesner and Ragozzino, 2003;
Browning et al., 2005; Barker et al., 2007; Barker andWarburton,
2009). The mPFC is innervated by several neuromodulatory sys-
tems, including inputs from the nucleus basalis, and blockade of
mAChRs in mPFC impairs object-in-place memory (Barker and
Warburton, 2009).However, themechanisms bywhichmAChRs
regulate object-in-place memory in mPFC are unknown.
There are five mAChR subtypes (M1 to M5) that couple to
numerous intracellular cascades andmembrane channels (Levey,
1996; Eglen, 2006). Pharmacological activation of mAChRs facil-
itates induction of long-term potentiation (LTP) in various brain
regions (Blitzer et al., 1990; Burgard and Sarvey, 1990; Bro¨cher et
al., 1992; Patil et al., 1998) and, under some circumstances, pro-
duces a lasting enhancement of synaptic transmission in hip-
pocampus (Ito et al., 1988; Auerbach and Segal, 1994, 1996;
Kojima and Onodera, 1998). Blockade of acetylcholine receptors
can also block induction of LTP (Hirotsu et al., 1989; Katsuki et
al., 1992; Kobayashi et al., 1997; Hess and Donoghue, 1999).
Furthermore, mAChR activation facilitates (Kirkwood et al.,
1999) or induces LTD in visual cortex (McCoy and McMahon,
2007) and induces LTD in perirhinal cortex (Massey et al., 2001).
Activation of mAChRs can either increase (Markram and Segal,
1990; Harvey et al., 1993; Buchanan et al., 2010) or decrease (Jo et
al., 2010)NMDA-mediated transmission, and thismodulation of
NMDARs may explain, at least in part, how mAChRs can affect
synaptic plasticity.
Despite the known role of acetylcholine in mPFC-dependent
learning andmemory (Dunnett et al., 1990; Broersen et al., 1995;
Ragozzino and Kesner, 1998; Dalley et al., 2004; Ross et al., 2005;
Barker and Warburton, 2009), there is little known about how
mAChRs influence synaptic plasticity in mPFC. Recent data in-
dicate that pharmacological mAChR activation enhances gluta-
matergic transmission in mPFC (Shirey et al., 2009) or produces
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LTD (Wang and Yuan, 2009; Huang and Hsu, 2010). In this
study, we first confirm that activation of mAChRs can trigger
LTD in mPFC (Wang and Yuan, 2009; Huang and Hsu, 2010).
Second, we show for the first time that theM1 potentiator BQCA
enhances LTD. Third, we demonstrate the induction of a form of
activity-dependent LTD that relies solely on release of endoge-
nous acetylcholine. These results are the first to demonstrate that
endogenous acetylcholine released by synaptic stimulation is suf-
ficient to produce long-term plasticity of AMPA-mediated trans-
mission in mPFC.
Materials andMethods
Tissue slices.Methods for obtaining whole-cell voltage-clamp recordings
were similar to those described previously (Caruana and Chapman,
2008; Griffiths et al., 2008; Garden et al., 2009) and experiments were
conducted in accordance with the UK Animals (Scientific Procedures)
Act 1986. Briefly, male Dark Agouti rats (P30 on day of use; B and K
Universal) were anesthetized with isoflurane, decapitated, and their
brains were rapidly removed and transferred into cold (4°C) artificial
CSF (ACSF) saturated with 95%O2 and 5%CO2 containing (inmM) 124
NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 1MgSO4, 10 D-glucose, and 2
CaCl2. Unless stated, all reagents were obtained from Sigma (Sigma Al-
drich). Coronal slices (400 m thick) were cut using a vibratome (DTK-
1000, Ted Pella), and slices recovered for 1 h at 22–24°C. Slices were
transferred individually to a recording chamber and visualized using an
upright microscope (Eclipse E600 FN, Nikon Instruments) equipped
with differential interference contrast optics, a 40 water-immersion
objective, and a near-infrared camera (C7500–11, Hamamatsu Photon-
ics). Submerged slices were superfused with oxygenated ACSF at a rate of
2.0ml/min at room temperature (22–24°C). Slices containing themedial
prefrontal cortex were taken from sections located within 2.2–4.2 mm
anterior to bregma (Paxinos and Watson, 1998).
Stimulation and recording. Patch recording pipettes for whole-cell re-
cordings were prepared from borosilicate glass (1.5 mm outer diameter,
2.0–3.5M; Harvard Apparatus) using a horizontal puller (P-97, Sutter
Instrument) and were filled with a solution containing (in mM) 130
CsMeSO4, 8 NaCl, 10 HEPES, 0.5 EGTA, 4 Mg-ATP, 0.3 Na-GTP, and 5
QX-314-Cl (pH adjusted to 7.25 with CsOH; 280–290 mOsm). Pi-
pettes were placed in contact with somata of layer V neurons and gentle
suction was applied under voltage clamp to form a tight seal (1–3 G).
Whole-cell configuration was achieved by increased suction, and exper-
iments began after cells stabilized (typically within 10–15 min following
break-in). Voltage-clamp recordings (Vh  70 mV) were obtained
using an Axopatch 200B amplifier (Molecular Devices) and displayed on
a computer monitor using the software package WinLTP (v1.11b for
Windows; WinLTP). Recordings were filtered at 5 kHz and digitized at
20 kHz (Digidata 1322A, Molecular Devices) for storage on computer
hard disk (using a Pentium-based Windows PC; Viglen). No correction
was applied to compensate for liquid junction potentials. Only cells with
a series resistance (Rs)25 M and a20% change in Rs from baseline
during the course of an experiment were included for analysis. Two
concentric bipolar stimulating electrodes (CBAPB50, FHC) were posi-
tioned along the layer I–II border at sites dorsal to and ventral to the
recording electrode located in layer V (Fig. 1A). Synaptic responses were
evoked with 0.1 ms constant current pulses delivered using two stimulus
isolation units (Model DS3, Digitimer), and stimulation intensity was
adjusted to evoke synaptic currents75%ofmaximal amplitude (range;
75–300A). Single test pulses or pairs of stimulation pulses (with a 50ms
interpulse interval) were delivered alternately to each stimulation site at a
frequency of 0.016 Hz to evoke EPSCs. Attempts to induce activity-
dependent LTD in the prelimbic region were made by delivering low-
frequency stimulation (LFS) to one of the two stimulation sites (selected
at random) in the superficial layers. The second stimulation site served as
an unconditioned control pathway in these experiments. LFS protocols
consisted of 300 or 450 pairs of stimulation pulses (with a 50 ms inter-
pulse interval) delivered to layer I/II at a frequency of 1 Hz, or 450
single-pulses delivered at 1 Hz. Test stimulation and LFS protocols were
configured and controlled usingWinLTP. All neurons included for anal-
ysis were identified visually as pyramidal cells based on the shape of
somata andwere located between550 and 850mfrom the pial surface
of the slice in layer V.
Data analysis. Evoked synaptic currents were analyzed using the soft-
ware applications WinLTP and AxoGraph X (v1.3.5 for Mac; AxoGraph
Scientific). Peak amplitudes of EPSCs were measured relative to the pre-
stimulus baseline (8–2 ms period before stimulation pulse), and paired-
pulse facilitation was determined by expressing the amplitude of the
second response as a proportion of the amplitude of the first response.
Input resistance (Rin) was calculated by measuring the amplitude of the
steady-state current evoked during a 5 mV voltage step (50 ms dura-
tion) delivered 100 ms before test stimulation, and Rs was calculated by
measuring the peak amplitude of the fast capacitive transient observed at
the onset of the voltage step. The amplitude (A) and membrane time
constant () of EPSCs were measured based on the average of five con-
secutive responses recorded at different times during an experiment
(specified below). The membrane time constant was first calculated by
fitting the decay of the synaptic current with two exponentials using
Clampfit (v10.2 for Windows; Molecular Devices). The value of the
weighted time constant (w) was then calculated using the following:
w  1A1/(A1A2)  2A2/(A1A2) (Bartlett et al., 2007).
Concentration-response curves were generated with Prism (v5.0d for
Mac; GraphPad Software) and fit using the least-squares (ordinary)
method. Comparisons of curve-fits used to determine EC50 values were
made using sum-of-squares F tests. The coefficient of variation (1/CV2;
where Cmean and VSD) was calculated on the mean amplitude of
responses obtained during 10 min epochs of stable recordings of EPSCs
using Excel (v2011 for Mac; Microsoft). The stability of responses was
first confirmed by testing the slope of a regression line fit through data
points included for 1/CV2 analyses, and results for 1/CV2 analyses were
expressed as a ratio of the baseline for plotting. The effects of bath or
intracellularly applied drugs during pharmacological experiments were
assessed on the amplitude of averaged EPSCs obtained during 5 min
epochs recorded at different times during an experiment (latencies spec-
ified below). All data were expressed as the mean  SEM and were
normalized to baseline recordings for plotting. Changes in response
properties were assessed with Prism using (where appropriate) paired or
unpaired samples t tests, one-way ANOVAs, or repeated-measures
ANOVAs.Post hoc comparisonsweremade using the Bonferronimethod
with an  level of p 0.05.
Pharmacology. Unless stated, all compounds used for pharmacological
experimentswere obtained fromTocris Bioscience and prepared as concen-
trated stock solutions (typically 10–50mM) by dilution in (where appropri-
ate) either distilled water or dimethyl sulfoxide and stored at 20°C until
required. To examine the role of the cholinergic system in modulating syn-
aptic transmission in mPFC, multiple concentrations of the nonselective
cholinergic agonist (2-Hydroxyethyl) trimethylammonium chloride car-
bamate (carbachol; from 10 nM up to 100 M) were bath applied. In some
experiments the acetylcholinesterase inhibitors (3aS)-cis-1,2,3,3a,8,8a-
Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol methylcarbamate
hemisulfate (physostigmine; 2 M) or 1,5-Bis(4-allyldimethylammonium-
phenyl)pentan-3-one dibromide (BW 284c51; 200 nM; obtained from
Sigma) were used. The contribution of muscarinic receptors to carbachol-
mediated changes in basal synaptic transmission was assessed by using the
nonselectivemuscarinic receptorantagonists (a,S)-a-(Hydroxymethyl)ben-
zeneacetic acid (1a,2b,4b,5a,7b)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,
4]non-7-yl ester hydrobromide (scopolamine; 10M) or (endo,syn)-()-3-
(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-
azonia bicyclo[3.2.1]octane bromide (atropine; 1 M), the M1 antagonists
5,11-Dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b]
[1,4]benzodiazepin-6-one dihydrochloride (pirenzepine; 0.5M), orN-[3-
Oxo-3-[4-(4-pyridinyl)-1-piper azinyl]propyl]-2,1,3-benzothiadiazole-4-
sulfonamide (VU0255035; 10 M), the M1 receptor agonists 4-[[[(3-
Chlorophenyl)amino]carbonyl]oxy]-N,N,N-trimethy l-2-butyn-1-
aminium chloride (McN-A-343; 3 M), or cis-2-Methylspiro[1,3-
oxathiolane-5,3	-quinuclidine] hydrochloride (AF102B; 100 M), or the
M1-selective positive allostericmodulator 1-(4-Methoxybenzyl)-4-oxo-1,4-
dihydro-3-quinoline carboxylic acid (BQCA; 10 M; obtained from Enzo
Life Sciences). The involvement of NMDA receptors (NMDARs) and
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metabotropic glutamate receptors (mGluRs) was examined using D- (-)-2-
Amino-5-phosphonopentanoic acid (D-AP5; 50 M) or (5R,10S)-(-)-5-
Methyl-10,11-dihydro-5H-dibenzo[a,d]cylcohepten-5,10-imine maleate
(MK-801; 3 mM; loaded intracellularly), and (2S)-2-Amino-2-[(1S,2S)-2-
carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495; 100
M), respectively, and the role of intracellular Ca2was assessed by loading
cells with 10 mM 1,2-Bis(2-aminophenoxy)ethane-N,N,N	,N	-tetraacetic
acid (BAPTA). Involvement of protein kinase C (PKC) was determined
using 3-[3-[2,5-Dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-
pyrrol-3-yl]-1H-indol-1-yl]propyl carbamimidothioic acid ester mesylate
(Ro-31–8220; 2.5M; bath applied), 3-[(8S)-8-[(Dimethylamino)methyl]-
6,7,8,9-tetrahydropyr ido[1,2-a]indol-10-yl]-4-(1-methyl-1H-indol-3-yl)-
1H-pyrrole-2,5-dione hydrochloride (Ro-32–0432; 10 M; loaded
intracellularly) or the pseudosubstrate peptide inhibitor of PKC (PKC (19–
36); 10 M; loaded intracellularly), and the contribution of nitric oxide to
carbachol-mediated changes inEPSCswas assessedby continuousperfusion
of the nitric oxide synthase inhibitor NG-Nitro-L-arginine methyl ester hy-
drochloride (L-NAME; 50M).
Results
Activation of acetylcholine receptors induces LTD in the
prelimbic region
EPSCs were evoked in layer V pyramidal cells following intracor-
tical stimulation of superficial layer afferents for both the dorsal
and ventral stimulation sites. Placement of the stimulating elec-
trodes in layers I/II was determined based on the convergence
and density of afferent fibers originating from the hippocampus
(Jay and Witter, 1991) and perirhinal cortex (Delatour and Wit-
ter, 2002) that terminatewithin the prelimbic region of themPFC
Figure 1. Bath application of carbachol induces LTD of EPSCs in the prelimbic region. A, Schematic diagram illustrating the placement of stimulating and recording electrodes in coronal slices
containing the mPFC. Two stimulating electrodes are positioned along the layer I/II border at sites dorsal to (Dorsal Stim) and ventral to (Ventral Stim) the recording electrode in layer V (ILC,
infralimbic cortex; Cg2, cingulate cortex; M1, primary motor cortex; M2, secondary motor cortex). Image modified from the atlas of Paxinos and Watson (1998) at a position2.7 mm anterior to
bregma.B, EPSCs are depressed by bath application of 10M carbachol. Numbered traces inB1 show representative EPSCs evoked at the time points indicated by the corresponding numbers inB2
for thedorsal and ventral stimulation sites.Meandata inB2highlight twodistinct phases to thedepressionof EPSCs inducedby carbachol: a potent but transient depressionof responses lasting30
min (tLTD) followed by recovery to a sustained depression of transmission (sLTD). Bath application of carbachol is marked by the gray bar and data are expressed as a percentage change in the
baseline amplitude of EPSCs (mean SEM) in this and subsequent figures, unless noted otherwise. Separate time-matched control data (filled triangles) are superimposed in B2 and indicate that
EPSCs are stable for 100 min in the absence of any pharmacological treatment. Note that Rs (B3) and Rin (B4) are unaffected by carbachol. C, There is no difference in the amount of tLTD and sLTD
induced by carbachol when comparing responses evoked by stimulating either the dorsal or ventral site (ns, not significant; *p 0.05). Data points for individual experiments are superimposed on
summary histograms in this and subsequent figures. D, Carbachol has concentration-dependent effects on the amplitude of EPSCs evoked in the prelimbic region. A summary of results for
experiments assessing the effects of increasing concentrations of carbachol (from10 nM to 100M) on evoked synaptic responses is shown inD1.D2, Concentration-response curves generated from
data inD1 show the depression of EPSCs relative to control responses (Ctrl) averaged over 5min epochs during the peak of tLTD (filled circles) and the last 5min of recording (sLTD; open circles) for
the five concentrations of carbachol tested. The EC50 for carbachol is 0.7M for tLTD and 11.2M for sLTD.
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(Hoover andVertes, 2007). Additionally, anatomical data suggest
that cholinergic projections to the mPFC are most dense in the
superficial layers (Mrzljak et al., 1995). Figure 1A shows a sche-
matic diagram illustrating the placement of stimulating and re-
cording electrodes in the mPFC, and example EPSCs are shown
in Figure 1B1 (gray traces; recorded during baseline and indicated
by the number 1). To determine whether activation of cholin-
ergic receptors modulates basal synaptic transmission in the pre-
limbic region, the nonselective cholinergic agonist carbachol (10
M) was bath applied to slices of medial prefrontal cortex for 20
min and then washed out with normal ACSF (n 10). As shown
in Figure 1B2, carbachol induced a rapid and potent transient
depression (tLTD) in the amplitude of EPSCs (lasting for 30
min), which partially recovered to a steady-state sustained long-
term depression of synaptic transmission (sLTD), and persisted
for the remainder of the experiment. Responses were reduced to
32.0 3.4% and 25.1 3.2%of baseline levels during the peak of
the tLTD phase for the dorsal (filled circles) and ventral (open
circles) stimulation sites, respectively (tLTD phase defined as the
5 min period of maximal inhibition induced by carbachol), and
were significantly depressed relative to responses evoked during
separate time-matched control experiments (Fig. 1B2, filled tri-
angles, n 4; F(2,21) 63.94, p 0.0001; dorsal, Bonferroni, p
0.0001; ventral, Bonferroni, p  0.0001). Further, synaptic
responses remained significantly depressed at 53.7  5.8% and
48.7 3.9% of baseline during the last 5 min of the experiment
(sLTD phase) for the dorsal and ventral stimulation sites, respec-
tively, when compared with control responses (F(2,21)  15.96,
p  0.0001; dorsal, Bonferroni, p  0.001; ventral, Bonferroni,
p 0.0001). The magnitude of tLTD and sLTD induced by car-
bachol did not differ between dorsal and ventral stimulation sites
(Fig. 1B,C; tLTD dorsal vs ventral, Bonferroni, p  0.54; sLTD
dorsal vs ventral, Bonferroni, p 1.00). Therefore, data obtained
for each site were averaged for subsequent experiments described
below. The depression of EPSCs was also significantly larger dur-
ing tLTD than during sLTD (Fig. 1C; averaged, t(9)  5.74, p 
0.001). The effects of carbachol were not associated with changes
in the weighted time constant of EPSCs recorded during tLTD or
sLTD (n  9; baseline, 100.0  26.1%; tLTD, 116.8  30.5%;
sLTD 101.0 27.7%; F(2,16) 1.25, p 0.31; data not shown).
Additionally, there was no significant change in Rs or Rin (Fig.
1B3,B4, respectively; Rs, t(9) 2.09, p 0.07; Rin, F(2,18) 0.84,
p 0.45), indicating that the tLTD and sLTD of EPSCs induced
by carbachol did not result from changes in electrical access or
membrane resistance.
The effects of carbachol on synaptic responses are
concentration dependent
Twenty minute application of 10 nM carbachol (Fig. 1D1, filled
triangles; n 4) did not induce any significant tLTD or sLTD of
synaptic responses when compared with time-matched control
experiments (n 4; tLTD, t(6) 1.38, p 0.22; sLTD, t(6) 0.40,
p 0.71). Bath application of 100 nM carbachol (Fig. 1D1, open
circles; n 5) induced tLTD of EPSCs, but no lasting depression
of synaptic transmission (tLTD, t(7) 5.55, p 0.001; sLTD, t(7)
0.70, p 0.51). However, application of 1 M (filled circles; n
3), 10 M (open squares; n  10), or 100 M carbachol (filled
squares; n 3) induced tLTD and sLTDof EPSCs in themPFC in
a concentration-dependentmanner (1M, tLTD, t(5) 5.10, p
0.01, sLTD, t(5) 3.64, p 0.05; 10M, tLTD, t(12) 11.70, p
0.0001, sLTD, t(12) 5.820, p 0.0001; 100M, tLTD, t(5) 13.06,
p 0.0001, sLTD, t(5) 10.47, p 0.0001). Results of nonlinear
curve fitting for concentration-responses curves generated by
comparing tLTD and sLTD of EPSCs induced by carbachol (Fig.
1D2) revealed a significant difference between the fit of the curves
for tLTD and sLTD (F(2,54)  18.53, p  0.0001). Based on the
curve-fits, the EC50 value for tLTD was determined to be 0.7 M,
which differed from the value of 11.2 M obtained for sLTD.
Furthermore, there was a positive linear correlation between the
amount of tLTD and sLTD induced by increasing concentrations
of carbachol (R2 0.74; data not shown).
Varying carbachol duration and stimulation parameters
Levels of tLTD and sLTDwere compared following bath applica-
tion of 10 M carbachol for a duration of either 5 (open circles;
n  5), 20 (gray filled circles; n  10), or 40 min (black filled
circles; n 5) (Fig. 2A1). EPSCs were depressed to 32.2 2.8%,
28.6 2.7%, and 22.7 3.7% of baseline during tLTD following
5, 20, or 40 min application of carbachol, respectively, and tLTD
did not differ significantly between the three application times
tested (Fig. 2A2; tLTD, F(2,17)  1.80, p  0.20). In addition,
sLTDwas 53.8 7.3%, 52.2 4.2%, and 45.6 5.6%of baseline
levels following 5, 20, or 40 min of carbachol application, respec-
tively, and sLTD did not differ significantly across the three ap-
plication times (Fig. 2A2; sLTD, F(2,17)  0.51, p  0.61). These
data indicate that varying the application time of carbachol had
no significant effect on themagnitude of tLTD and sLTD induced
in the medial prefrontal cortex.
To assess whether synaptic stimulation was required for the
induction of carbachol-mediated LTD, the delivery of test stim-
ulation to one input was paused for 50 min at the start of carba-
chol application (10 M for 20 min) and levels of sLTD were
compared, after synaptic stimulation had resumed, to levels of
sLTD in the uninterrupted input (Fig. 2B1; n  4). Synaptic
responses were depressed by carbachol to 55.2 4.3%of baseline
in the nonstimulated input; this depression was not significantly
different from the sLTD of EPSCs induced by carbachol in the
alternate input that receivedcontinuous test stimulation throughout
the experiment (57.2 3.5%; Fig. 2B2; sLTD, t(3) 0.42, p 0.70).
These data suggest, therefore, that constant synaptic drive is not
required for the induction of carbachol-mediated LTD in the pre-
limbic region.
Levels of tLTD and sLTD induced by application of 10 M
carbachol were compared following stimulation of either super-
ficial layer (LI/II) or deep layer (LV) inputs to layer V pyramidal
cells (Fig. 2C1; n  5). EPSCs induced by stimulation of the
superficial layers were depressed to 28.2 4.0% and 53.8 3.1%
of baseline for tLTDand sLTD, respectively. Responses evoked by
stimulation of deep layer inputs to the same cells were depressed
to 32.7 7.0% and 62.5 4.8% of baseline for tLTD and sLTD,
respectively. Levels of tLTD and sLTD induced by carbachol did
not differ significantly when comparing responses evoked by su-
perficial or deep layer stimulation (Fig. 2C2; tLTD, t(4)  0.69,
p 0.53; sLTD, t(4) 1.74, p 0.16).
Activation of muscarinic receptors is required for
carbachol-mediated LTD
To determine the involvement of mAChRs in tLTD and sLTD of
EPSCs induced by carbachol, the nonselective mAChR antago-
nist scopolamine (10 M) was coapplied with 10 M carbachol
(n  5). Application of scopolamine alone for 15 min had no
significant effect on basal synaptic transmission but blocked both
the tLTD and sLTD of synaptic responses typically induced by
carbachol (Fig. 3A1). In the presence of scopolamine, the ampli-
tude of EPSCs was reduced by carbachol to 87.8  10.0% and
89.1 7.6% of baseline for tLTD and sLTD, respectively, but this
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reduction was not significant when com-
pared with responses evoked during
separate time-matched control experi-
ments (tLTD, Bonferroni, p  1.00;
sLTD, Bonferroni, p 1.00). In addition,
levels of tLTD and sLTD in slices treated
with scopolamine were significantly less
than those observed in control slices that
received only carbachol (tLTD, F(2,16) 
47.35, p 0.0001, Bonferroni, p 0.0001;
sLTD, F(2,16) 19.15, p 0.0001, Bonfer-
roni, p 0.001). Together, these findings
indicate that both the tLTD and sLTD of
EPSCs induced by carbachol aremediated
by activation of mAChRs. Interestingly,
scopolamine had no effect on established
sLTD (Fig. 3A2, filled circles; n  4); re-
sponses remained depressed at 59.3 
7.0% of baseline during sLTD (F(2,18) 
41.52, p  0.0001, Bonferroni, p 
0.0001), and the level of sLTD did not dif-
fer significantly from levels in carbachol-
treated control slices not exposed to
scopolamine (Fig. 3A2, open circles;n 7;
Bonferroni, p 1.00).
To further confirm that the tLTD and
sLTD of EPSCs induced by carbachol are,
indeed, mediated by activation of musca-
rinic receptors, an additional nonselective
muscarinic receptor antagonist, atropine
(1 M), was tested (Fig. 3B, filled circles;
n  4). Similar to results obtained with
scopolamine, coapplication of atropine
with carbachol blocked both the tLTD and
sLTDofEPSCsnormally observedwith car-
bachol alone. Responses remained stable at
100.3 6.3% and 103.5 3.8% of baseline
for tLTDandsLTD, respectively, andEPSCs
were significantly larger than thoseobtained
following bath application of carbachol
alone (tLTD, F(2,18)  89.82, p  0.0001,
Bonferroni, p  0.0001; sLTD, F(2,18) 
46.92, p 0.0001, Bonferroni, p 0.0001).
Similar to results obtained with scopol-
amine, the magnitude of tLTD and sLTD
did not differ significantly from time-
matched control responses following coap-
plication of atropine and carbachol (tLTD,
Bonferroni, p 1.00; sLTD, Bonferroni, p 1.00).
M1 receptor activation is required for sustained LTD in the
prelimbic region
Of the five known subtypes of mAChRs found throughout the
brain (M1 toM5) (Levey, 1996; Eglen, 2006), the M1 receptor has
been shown to play a critical role in learning and memory func-
tions mediated by the mPFC (Shirey et al., 2009). To assess con-
tributions of M1 receptors to the carbachol-mediated tLTD and
sLTD of EPSCs, the selective M1 receptor antagonist pirenzepine
was coapplied with 10 M carbachol (0.5 M; n 5) (Massey et
al., 2001). Under these conditions (Fig. 3C1; n  5), responses
were reduced by carbachol to 53.6 7.2% of baseline levels dur-
ing tLTD, and although the amplitude of EPSCs was depressed
significantly relative to control responses (F(2,16)  46.79, p 
0.0001, Bonferroni, p 0.001), the amount of tLTD was signifi-
cantly less than that observed during separate control experi-
ments with carbachol alone (Bonferroni, p 0.01). Interestingly,
carbachol reduced the amplitude of EPSCs during sLTD to
74.8 4.3% of baseline levels in the presence of pirenzepine (Fig.
3C1), but this reduction was not significantly different from un-
treated controls (F(2,16)  19.30, p  0.0001, Bonferroni, p 
0.06), and the amount of sLTD was significantly less than the
amount of sLTD induced by carbachol alone (Bonferroni, p 
0.05). Together, these data indicate that there is a significant M1-
mediated component that contributes to the lasting sustained
depression of EPSCs induced by carbachol.
To further evaluate the role ofM1 receptors, additional exper-
iments were also performed using the highly selective M1 recep-
tor antagonist, VU0255035 (Sheffler et al., 2009). Coapplication
Figure2. Induction of carbachol-mediated LTDdoes not depend on the duration of agonist application, afferent synaptic drive,
or stimulationof a specific cortical layer.A, Bathapplicationof 10Mcarbachol for 5, 20, or 40min induces similar levels of tLTDand
sLTD in the prelimbic region. Group data showing the onset of carbachol-LTD for each application time are plotted together in A1,
and the amount of depression observed during the peak of tLTD and sLTD is shown inA2.B, Synaptic stimulation is not required for
the induction of sLTD of EPSCs. Synaptic responses are depressed by carbachol despite a temporary pause in the delivery of test
stimuli to one inputduringandafter bathapplicationof carbachol (B1; NoStim, filled circles). Arrows indicate the timeswhen stim-
ulation was paused and then resumed to the test input (Stim On/Stim Off). Inset traces show representative EPSCs for the
stimulated (Stim) andnonstimulated (NoStim) inputs at the timepoints indicatedby thenumbers inB1. Averageddata inB2 show
that the amount of sLTD inducedby carbachol is the same inboth the stimulated andnonstimulated inputs.C, Similar levels of tLTD
and sLTD are induced by carbachol following stimulation of either layers I/II or layer V. Group data for EPSCs evoked by layer I/II
(filled circles) or layer V (open circles) stimulation are shown in C1, and the amount of depression observed during the peak of tLTD
and sLTD is shown in C2.
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of 10 M VU0255035 with carbachol (Fig. 3C2, filled circles; n
5) had no effect on the magnitude of tLTD when compared with
control experiments with carbachol alone, but blocked the sus-
tained depression of EPSCs. Responses were significantly re-
duced to 38.5  6.7% of baseline during tLTD when compared
with time-matched controls (F(2,19) 86.52, p 0.0001, Bonfer-
roni, p  0.0001), but did not differ significantly from controls
during carbachol-induced tLTD (Bonferroni, p 1.00). The am-
plitude of EPSCs returned to 91.4 5.0% of baseline and did not
differ significantly from time-matched controls (F(2,19) 35.06,
p  0.0001, Bonferroni, p  0.24), but was significantly greater
than responses recorded following application of carbachol alone
(Bonferroni, p 0.001). These data provide further evidence in
favor of a role for M1 receptors in mediating the sLTD of EPSCs
induced by carbachol.
To further examine the role of M1 receptors in acetylcholine-
mediated LTD, the selective M1 receptor agonists McN-A-343 (3
M; n 4; Fig. 4A1) or AF102B (100 M; n 4; Fig. 4A2) were
bath applied to slices ofmPFC. Perfusion of eitherMcN-A-343 or
AF102B induced a slow-onset depression of synaptic transmis-
sion that differedmarkedly from the biphasic depression induced
by carbachol. Twenty-five minutes after the start of McN-A-343
application, the transient depression of EPSCs (72.2  7.7% of
baseline) was significantly less than the depression induced by
carbachol alone (Fig. 4B; tLTD, F(2,15) 58.06, p 0.0001, Bon-
ferroni, p 0.0001). A similar result was obtained for tLTDusing
AF102B (Fig. 4B; tLTD, 80.1 8.4% of baseline; F(2,18) 66.00,
p  0.0001, Bonferroni, p  0.0001). In contrast, EPSCs were
significantly depressed by McN-A-343 or AF102B to 54.8 
18.1% and 58.3  4.7% of baseline, respectively during sLTD,
when compared with time-matched control responses (McN-A-
343,F(2,15) 7.67, p 0.01, Bonferroni, p 0.05; AF102B,F(2,18)
51.48, p 0.0001, Bonferroni, p 0.0001), and the level of sLTD
induced by either agonist did not differ significantly from levels in-
duced by carbachol alone at a similar latency (Fig. 4B; sLTD:McN-
A-343, Bonferroni, p 1.00; AF102B, Bonferroni, p 1.00). These
Figure3. Carbachol-mediated LTD of EPSCs in the prelimbic region requires activation ofmuscarinic receptors.A, Application of the nonselectivemuscarinic receptor antagonist scopolamine (10
M) blocks both the tLTDand sLTD inducedby carbachol. Groupdata inA1 show theblock of carbachol-LTDby scopolamine (filled circles) plotted togetherwith control data for separate experiments
in which 10M carbachol was applied alone (open circles). The black bar denotes the latency and duration of scopolamine bath application. Inset traces show representative EPSCs recorded at the
time points indicated by the numbers. Interestingly, the sLTD of EPSCs is not reversed by scopolamine once carbachol-mediated LTD has already been established (A2).B, Coapplication of a different
nonselectivemuscarinic receptor antagonist, atropine (1M), also blocked both the tLTD and sLTD of EPSCs induced by carbachol. C, The carbachol-mediated LTD of EPSCs involves activation of M1
receptors.Bathapplicationof theM1antagonistpirenzepine (0.5M) significantlyattenuatesboth the tLTDandsLTDofEPSCs inducedbycarbachol (C1).Note that there is still significant residual tLTDandsLTD
induced by carbachol in the presence of pirenzepine. In contrast, the potent M1 antagonist VU0255035 (10M) blocked the sLTD of EPSCs induced by carbachol, but had no effect on the initial transient
suppression (C2).D, Histogram summarizing the depression of EPSCs induced by carbachol in the presence and absence ofmuscarinic receptor antagonists for both tLTD and sLTD. *p 0.05.
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results suggest that direct activation ofM1 receptors by eitherMcN-
A-343 or AF102B induces sLTD but not tLTD.
Enhancing the efficacy of M1 receptors facilitates induction of
carbachol-mediated LTD
An alternative approach to determine the contributions of mus-
carinic receptors to the depression of EPSCs is to use subtype-
selective allosteric modulators for mAChRs that can enhance or
suppress the functioning of target receptors by modulating re-
sponses mediated by traditional orthosteric binding. The com-
pound BQCA is a positive allosteric modulator that is highly
selective for M1 receptors (Ma et al., 2009; Shirey et al., 2009). As
shown in Figure 4C1, bath application of BQCA alone for 15 min
had no significant effect on basal synaptic transmission in the
prelimbic region (n 5). At a concentration of 100 nM, carbachol
typically only induces tLTD of EPSCs and no sLTD of synaptic
responses (Fig. 4C2, open circles; n 5).However, pairing BQCA
with 100 nM carbachol significantly enhanced the effects of 100
nM carbachol alone (Fig. 4C2, filled circles; n 5; tLTD, F(2,17)
16.04, p 0.0001; sLTD, F(2,17) 10.55, p 0.01). EPSCs were
significantly depressed to 30.5 6.7% and 62.6 3.4% of baseline
during tLTD and sLTD, respectively, relative to data obtained with
100 nM carbachol alone (tLTD, Bonferroni, p 0.001; sLTD, Bon-
ferroni, p 0.05), and levels of tLTD and sLTD induced by pairing
BQCA and 100 nM carbachol were not significantly different from
levelsobserved inexperimentswith10Mcarbachol alone (see sum-
mary inFig. 4D; tLTD,Bonferroni,p 1.00; sLTD,Bonferroni,p
0.58). Together, these findings further suggest that the sLTD
of EPSCs induced by carbachol is mediated primarily through
activation of M1 muscarinic receptors.
tLTD and sLTD are mediated by different receptors on
opposite sides of the synapse
The results listed above for experiments using selectiveM1 recep-
tor agonists, M1 allosteric modulators, and M1 antagonists
strongly suggest that the sLTD of EPSCs induced by carbachol is
Figure4. The sustaineddepression of EPSCs ismimickedby activation ofM1 receptors.A, Bath application of the selectiveM1 receptor agonistMcN-A-343 (3M) for 20min induces sLTDof EPSCs
(A1). Data forMcN-A-343 (filled circles) are superimposedwith data for separate experiments inwhich 10M carbacholwas applied alone (open circles). Note thatMcN-A-343 induces a similar sLTD
as carbachol, but does not induce a rapid and potent transient suppression of synaptic responses. Similarly, bath application of another selectiveM1 receptor agonist, AF102B (100M), also induces
a slow-onset sLTD that lacks an initial tLTD phase (A2). B, Summary histogram comparing the depression of EPSCs induced by carbachol or by McN-A-343 or AF102B for both tLTD and sLTD. *p
0.05. C, Enhancing the sensitivity ofM1 receptors to carbachol converts a subthreshold concentration of carbachol into onewhich induces a lasting sLTD. TheM1-selective allosteric potentiator BQCA
(10M) has no significant effect on basal synaptic transmission in the mPFC (C1), but greatly enhances the efficacy of a subthreshold 100 nM concentration of carbachol (C2, filled circles). D, The
pairing of BQCA and 100 nM carbachol induces tLTD and sLTD of EPSCs that are statistically indistinguishable from results obtained with 10M carbachol alone. *p 0.05.
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mediated solely by activation of M1 receptors. Indeed, it is possi-
ble to generate completely new sets of data from carbachol con-
trol experiments that closely resemble results obtained for
separate experiments using either the M1 agonist AF102B or the
M1 antagonist VU0255035. As shown in Figure 5A1, subtracting
the data set obtained during the coapplication of VU0255035 and
carbachol from the time-matched control experiment in which
carbachol was applied alone produces a new data set that closely
resembles the results obtained from Figure 4A2 when the M1
agonist AF102B was applied alone (Fig. 5A1, filled circles vs filled
squares). Similar to the AF102B data set, the results from this
subtraction lack an initial tLTDphase andonly show a slow-onset
sLTD phase. In contrast, subtracting the AF102B data set from
the carbachol control data set produces results that closely
mimic those shown in Figure 3C2 during the coapplication of
VU0255035 and carbachol (Fig. 5A1, open circles vs open
squares). The resulting data set contains only a tLTD phase
and lacks any sustained depression of responses. In addition,
the data generated in Figure 5A2 in which the AF102B and
VU0255035carbachol data sets are combined provide fur-
ther evidence that tLTD and sLTD are mediated by M1-
independent and M1-dependent activation, respectively. In
this example, the addition of the two sets of experimental data
create a result (Fig. 5A2, filled circles) that almost perfectly
Figure 5. The carbachol-mediated sLTD of EPSCs depends on activation of postsynapticM1 receptors, whereas tLTD ismediated presynaptically by a reduction in glutamate release.A, Results for
experiments using selective M1 agonists and antagonists provide clues to a possible mechanistic dissociation between tLTD and sLTD. Subtracting the data set for experiments using the M1
antagonist VU0255035(carbachol) (see Fig. 3C2) from those during which carbachol was applied alone produces a new data set that closely resembles the results obtained with the M1 agonist
AF102B alone [A1; CChminus VU(CCh), filled circles; AF102B, filled squares]. Note, error bars from original data sets used for comparison have been removed for clarity. Similarly, subtracting the
AF102Bdata set (see Fig. 4A2) from carbachol control data produces resultswhich contain only a tLTDphasewith no sLTD, thereby resembling data obtainedwith VU0255035(carbachol) [A2; CCh
minus AF102B, open circles; VU(CCh), open squares]. Interestingly, combining the results for experiments with AF102B and VU0255035(carbachol) produces a data set that precisely mirrors
results obtained during control experiments when carbachol was applied alone (A2), suggesting that the sLTD of EPSCs is mediated solely by activation of M1 receptors. B, The onset of sLTD is
observedmore clearly when the effects of tLTD are subtracted. Bath application of 100 nM carbachol typically induces tLTD of EPSCs with no lasting sLTD of transmission (see Fig. 1D1, open circles).
As a result, the 100 nM data can be subtracted from the results for 1, 10, and 100M carbachol to better visualize the onset of sLTD. The results are shown inB1 for 1 (open circles), 10 (filled circles),
and 100 (open squares)M carbachol. Interestingly, the data obtainedwithMcN-A-343 (see Fig. 4A1) are nearly identical to the 10M carbachol data that has the tLTD component subtracted (B2).
C, The carbachol-mediated depression of EPSCs is expressed, in part, by a reduction in the release probability of glutamate. There was a significant increase in paired-pulse facilitation that was
time-locked to the tLTD of EPSCs induced by 10M CCh (C1; PPF, filled circles; EPSC amplitude, open circles). Interestingly, paired-pulse ratios returned to baseline levels during sLTD (summarized
in C2; *p 0.05). D, Bath application of carbachol also increased response-to-response variability during tLTD as indicated by a reduction in the coefficient of variation. Normalized 1/CV
2 was
computed for 10 min epochs of stable EPSCs recorded during the peak of tLTD (C1, latency indicated by the black bar) and during sLTD (C1, white bar) and expressed as a ratio of the baseline for
plotting. Similar to findings for paired-pulse facilitation, the reduction in 1/CV 2 observed during tLTD was transient (filled circles) and response-to-response variability returned to baseline levels
during sLTD (open circles).
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approximates those data obtained during experiments in
which carbachol was bath applied alone (Fig. 5A2, open cir-
cles). Together, these findings offer further support that the
sLTD of EPSCs is mediated by activation of M1 receptors.
As shown in Figure 1D1, bath application of 100 nM carbachol
(open circles) induced tLTD of EPSCs with no sLTD. Thus, sub-
tracting the 100 nM data set from results obtained for 1, 10, and
100 M carbachol allows sLTD to be visualized with little inter-
ference from transient effects of tLTD (Fig. 5B1). Interestingly,
the data obtained with McN-A-343 (from Fig. 4A1) are nearly
identical to the 10 M carbachol data that has the tLTD compo-
nent subtracted (see Fig. 5B2), and this further suggests that the
sLTD of EPSCs induced by carbachol is mediated, primarily, by
activation of M1 mAChRs.
In additional experiments, paired-pulse tests were used to
determine whether carbachol depresses EPSCs through a presyn-
aptic or postsynapticmechanism. Pairs of stimulation pulses sep-
arated by an interval of 50 ms were delivered before and after 20
min bath application of 10 M carbachol (Fig. 5C1; n  6).
Paired-pulse facilitation data in Figure 5C1 is shown superim-
posed together with the EPSC amplitude data from Figure 1D1.
Note that the tLTDof EPSCs induced by carbachol is time-locked
to a significant increase in paired-pulse facilitation. Although
paired-pulse facilitation increased significantly to 207.2 20.1%
of baseline levels following application of carbachol (Fig. 5C2;
F(2,9) 13.31, p 0.01; Bonferroni, p 0.01), the increase was
only transient, and the amount of facilitation returned to baseline
levels by the end of the experiment (to 123.2 4.4% of baseline;
Bonferroni, p 0.16). These data suggest that the tLTD of EPSCs
is mediated presynaptically by a reduction in glutamate release.
In addition, response-to-response variability in the amplitude
of EPSCs increased during tLTD, and this is reflected by a
reduction in normalized 1/CV 2 to 0.41  0.12 of baseline
computed for a 10 min epoch of stable EPSCs recorded during
the peak of tLTD (Fig. 5D, filled circles; n  10). Similar to
findings for paired-pulse facilitation, the reduction in 1/CV 2
observed during tLTD was transient and response-to-response vari-
ability returned to baseline levels during sLTD (to 1.04 0.36;
Fig. 5D, open circles). Together, these data suggest that the
tLTD of EPSCs is mediated presynaptically by a temporary
reduction in glutamate release and that the sLTD of synaptic
responses is not associated with a significant change in the
release probability of neurotransmitter.
The role of NMDARs, mGluRs, postsynaptic Ca2 signaling,
and PKC in carbachol-mediated LTD
Activation of NMDA receptors and mGluRs is important in the
induction of a variety of forms of synaptic plasticity. Bath appli-
cation of carbachol in the presence of the NMDAR antagonist
AP5 (50 M) resulted in tLTD and sLTD of EPSCs (19.4 7.5%
and 61.0  9.2% of baseline, respectively; Fig. 6A, filled circles;
n  4) that was not significantly different from control LTD
induced by carbachol alone (tLTD, F(2,15)  61.84, p  0.0001,
Bonferroni, p  0.57; sLTD, F(2,15)  13.82, p  0.001, Bonfer-
roni, p 0.86). In addition, carbachol-mediated LTD was unaf-
fected by application of the broad spectrum mGluR antagonist
LY341495 (100 M; Fig. 6B, filled circles; n  5; tLTD, 24.4 
3.2% of baseline; F(2,19)  151.7, p  0.0001, Bonferroni, p 
0.126; sLTD, 62.3 6.7% of baseline; F(2,19) 36.51, p 0.0001,
Bonferroni, p 1.00). To investigatewhether an increase in post-
synaptic calcium was required for carbachol-mediated LTD, ex-
periments were conducted in which the recording pipette
contained 10 mM BAPTA (n  8); this manipulation had no
effect on the magnitude of carbachol-LTD (responses were re-
duced to 29.8 2.4% and 66.9 7.4% of baseline for tLTD and
sLTD, respectively; Fig. 6C; tLTD, F(2,22)  170.4, p  0.0001,
Bonferroni, p 0.54; sLTD, F(2,22) 20.29, p 0.0001, Bonfer-
roni, p 0.63). It has previously been reported that nitric oxide is
required for carbachol-LTD in prefrontal cortex (Huang and
Hsu, 2010). However, the nitric oxide synthase inhibitor
L-NAME (50 M) had no effect on the tLTD and sLTD induced
by 10 M carbachol (EPSCs reduced to 26.6  2.4 and 59.4 
3.0% of baseline, respectively; Fig. 6D; n  6; tLTD, F(2,20) 
165.9, p  0.0001, Bonferroni, p  0.20; sLTD, F(2,20)  61.42,
p  0.0001, Bonferroni, p  0.62). Muscarinic receptors are
known to trigger metabotropic cascades that lead to the activa-
tion of PKC. To examine the role of PKC in carbachol-mediated
LTD, carbachol was bath applied in the presence of the extracel-
lularly applied inhibitor Ro-31–8220 (2.5M; Fig. 6E1; n 5) or
the intracellularly applied inhibitors PKC (19-36) (10 M; Fig.
6E2;n 5) orRo-32-0432 (10M;n 5; data not shown).Under
all three of these conditions tLTD was unaffected (Ro-31-8220,
45.9 8.1% of baseline, F(2,19) 67.19, p 0.0001, Bonferroni,
p 0.54; PKC (19-36), 26.0 3.2% of baseline, F(2,19) 148.3,
p  0.0001, Bonferroni, p  0.22; Ro-32-0432, 42.0  9.1% of
baseline, F(2,19)  62.07, p  0.0001, Bonferroni, p  1.00). In
contrast sLTD was blocked. Responses during sLTD were 99.4
4.7% of baseline in the presence of Ro-31-8220 (Fig. 6E1), 88.9
4.4% of baseline in cells loaded with PKC (19-36) (Fig. 6E2), and
94.2 2.2% of baseline in Ro-32-0432 (data not shown). Each of
these conditions were significantly different to sLTD induced by
carbachol alone (Ro-31-8220; Fig. 6E1; F(2,19) 39.66, p 0.0001,
Bonferroni, p 0.0001; PKC (19-36); Fig. 6E2, F(2,19) 36.77, p
0.0001, Bonferroni, p  0.001; Ro-32-0432, F(2,19)  46.84, p 
0.0001, Bonferroni, p  0.0001). These results show that LTD
induced by stimulation of acetylcholine receptors by carbachol does
not require additional activation of NMDA ormGluRs or increases
in intracellular calcium or the secondmessenger nitric oxide. How-
ever, there is a requirement for activation of PKC in carbachol-
mediated sLTD but not tLTD inmPFC.
Activation of M1 receptors facilitates induction of
activity-dependent LTD
We next investigated whether activity-dependent LTD can be
induced by synaptic stimulation in prefrontal cortex andwhether
such activity-dependent LTD shares properties with carbachol-
mediated LTD. LTD inmany brain preparations, especially in adult
cortex, is induced by delivery of paired-pulse low-frequency stimu-
lation (PP-LFS) (Kemp and Bashir, 2001; Caruana et al., 2007). To
begin this series of experiments we investigated the lower threshold
requirements for LTD.We first delivered 300 paired stimuli (50 ms
interpulse interval; 1 s between consecutive pairs). However, this
protocol did not result in LTD(Fig. 7A;n 6). Responses remained
stable at 96.98.9%ofbaseline levels anddidnotdiffer significantly
from responses evoked in a separate control pathway that did not
receive LFS (t(5) 0.48, p 0.65).
To investigate whether insufficient acetylcholine levels are a
limiting factor for LTD induction, we delivered 300 PP-LFS, but
in the presence of the acetylcholinesterase inhibitors physostig-
mine (2M; Fig. 7B1; n 6) or BW284c51 (200 nM; Fig. 7B2; n
4) to increase levels of acetylcholine in themPFC.Under either of
these conditions 300 PP-LFS resulted in significant and robust
LTD. EPSCs were reduced to 63.1  8.5% or 50.4  5.9% of
baseline levels for physostigmine or BW284c51, respectively, and
EPSCs were significantly depressed relative to control responses
(physostigmine, t(5) 3.29, p 0.05; BW 284c51, t(3) 7.78, p
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0.01). These data suggest that the levels of acetylcholine are an im-
portant factor inLTDinductionand further suggest that300PP-LFS
alone does not raise acetylcholine levels sufficiently to induce LTD.
Our previous data (Figs. 4, 5) suggests that M1 receptors are
important for induction of the sustained phase of LTD. To exam-
ine whether increasing M1 receptor activation specifically, as op-
posed to raising basal acetylcholine levels, would convert the 300
PP-LFS subthreshold stimulation into a suprathreshold stimula-
tion protocol, we delivered 300 PP-LFS in the presence of the
M1-positive allosteric modulator BQCA (10M; Fig. 7C1; n 5).
This pairing produced robust LTD (to 53.4  3.3% of baseline;
t(4)  8.51, p  0.001). Furthermore, LTD induced under these
conditions was prevented by the muscarinic antagonist scopol-
amine (10 M; Fig. 7C2; n  5). Responses remained stable at
89.3  7.2% of baseline and did not differ significantly from
control EPSCs (control responses were 89.1  5.2% of baseline
during the last 5 min of the experiment, t(4)  0.03, p  0.98).
These results suggest that 300 PP-LFS results in insufficient acti-
vation of M1 receptors by endogenous acetylcholine to induce
LTD. However, manipulations that increase acetylcholine levels
orM1 “potency” during such subthreshold stimulation can result
in the induction of LTD.
In the next series of experiments we used an alternative stim-
ulation protocol that was also subthreshold for LTD induction.
Thus, we found that 450 single-pulses delivered at a frequency of
1 Hz did not result in LTD (Fig. 8A1; n 5). Responses remained
stable at 94.5 3.2% of baseline levels and did not differ signif-
icantly from responses evoked in the control pathway (Fig. 8A2;
t(4)  0.45, p  0.67). However, 450 stimuli delivered in the
presence of the acetylcholinesterase inhibitor physostigmine (2
M) did result in LTD (Fig. 8B1; n 5). The amplitude of EPSCs
recorded during the last 5min of the experiment were reduced to
56.4  4.2% of baseline, and responses were significantly de-
pressed relative to the control input that did not receive LFS (Fig.
8B2; t(4)  6.32, p  0.01). Furthermore, 450 stimuli at 1 Hz,
delivered in the presence of 10 M BQCA, also produced robust
LTD (Fig. 8C1; n  5). Under these conditions, responses were
reduced to 42.6  5.3% of baseline that were significantly
depressed relative to control responses (Fig. 8C2; t(4) 8.30, p
0.01). Therefore, taken together, our results show that two differ-
Figure 6. Induction of carbachol-LTD does not require activation of NMDA receptors, mGluRs, or a rise in postsynaptic calcium, but depends critically on activity of protein kinase C. Coapplication
of either the NMDA receptor antagonist AP5 (A; 50M) or the mGluR antagonist LY341495 (B; 100M which blocks group I, II, and III mGluRs) does not prevent tLTD or sLTD induced by 10M
carbachol. In addition, loading cells with the calcium chelator BAPTA (C; 10 mM) or continuous application of the nitric oxide synthase inhibitor L-NAME (D; 50M) has no effect on tLTD and sLTD
induced by carbachol in the prelimbic region. E, The sustained depression of EPSCs requires activity of PKC. Continuous perfusion of the PKC inhibitor Ro-31-8220 (2.5M) blocks the expression of
sLTD, but not tLTD, induced by 10M carbachol (E1). Similarly, loading cells with the PKC inhibitor PKC (19-36) (10M) also prevents the expression of sLTD and has no effect on the transient
suppression of synaptic responses (E2).
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ent subthreshold induction paradigms can become suprathresh-
old for LTD induction simply by increasing cholinergic tone
and/or M1 muscarinic receptor activation.
A novel form of activity-dependent LTD that relies on
endogenous acetylcholine receptor activation
We next examined whether increasing the duration of the sub-
threshold stimulation protocol would result in LTD without the
need for pharmacological manipulation of muscarinic receptors.
Therefore, wemodified the induction protocol and increased the
number of pulse-pairs from 300 to 450 during 1 Hz LFS. This
protocol did, indeed, result in robust LTD (Fig. 9A; n 5). De-
livery of this LFS protocol reduced responses to 61.2  5.6% of
baseline levels and induced significant LTD of EPSCs relative to
responses in the control pathway that did not receive LFS (t(4)
3.22, p 0.05). In contrast, delivery of the same LFS stimulation
protocol within layer V did not induce significant LTD; responses
remained stable at 83.6  6.9% of baseline and did not differ
significantly from controls (t(5)  2.15, p  0.09; data not
shown). Interestingly, LTD induced by 450 PP-LFS was not
blocked by loading cells with the NMDAR antagonist MK-801 (3
mM, Fig. 9B; n  5); responses were reduced to 59.7  3.5% of
baseline and were significantly depressed relative to controls (t(4)
11.81, p 0.001).
In line with the signaling cascades found for carbachol-LTD,
the activity-dependent LTD induced by 450 PP-LFS was not
blocked by loading cells with BAPTA (10mM; Fig. 9C; n 5) but
was blocked by inhibition of PKC (Fig. 9D; n  6). Responses
remained stable at 84.5 11.8% of baseline during the pairing of
Ro-31-8220 (2.5 M) with PP-LFS, and EPSCs did not differ
significantly from control responses (t(5) 1.530, p 0.19). LTD
was also blocked by the muscarinic receptor antagonist scopol-
amine (10 M; Fig. 9E; n  5). Responses remained stable at
83.8  7.9% of baseline following the pairing of PP-LFS with
scopolamine, and EPSCswere not significantly depressed relative
to controls (control EPSCs were 89.3 4.7% of baseline during
the last 5 min of the experiment, t(4)  1.46, p  0.22). Fur-
thermore, this form of activity-dependent LTD in the prelim-
Figure 7. Enhancing either cholinergic tone or the sensitivity of M1 receptors converts a subthreshold LFS protocol into one which induces LTD. A, Delivery of 300 pairs of stimulation pulses (50
ms interpulse interval) at a frequency of 1 Hz (PP-LFS; gray bar) to one input (either the dorsal or ventral input; selected at random) fails to induce LTD in themPFC (filled circles; PP-LFS). The second
input (open circles; Control) did not receive LFS in this and subsequent figures. B, Enhancing cholinergic tone by blocking activity of acetylcholinesterases facilitates induction of LTD following
delivery of subthreshold LFS. Continuous perfusion of the acetylcholinesterase inhibitors physostigmine (B1; 2M) or BW 284c51 (B2; 200 nM) converts the subthreshold 300 PP-LFS protocol into
onewhich induces LTD. C, Enhancing the sensitivity of M1 receptors to acetylcholine also facilitates induction of LTD induced by subthreshold LFS. Pairing bath application of BQCA (10M)with the
300 PP-LFS protocol induced LTD in the prelimbic region (C1). Coapplication of scopolamine (10M)with BQCAduring PP-LFS blocks induction of LTD (C2).D, Summary histogram comparing results
obtained during delivery of 300 PP-LFS alone or together with treatments to enhance M1 receptor activation.
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bic region isM1 receptor-dependent: applicationof the selectiveM1
receptor antagonistVU0255035 (10M)blocked induction (Fig. 9F;
n 6). Responses did not differ significantly fromEPSCs evoked in
the unconditioned control pathway (t(5) 2.25, p 0.05). Under
these conditions, therefore, LTD relies on acetylcholine and PKC
activation and parallels the findings that carbachol-mediated LTD
relies on PKC but not postsynaptic increases in calcium. These re-
sults suggest thatLTDcanbe inducedprovided that sufficient release
of acetylcholine and activation ofM1 receptors is achieved. In addi-
tion, these results also indicate that with the stimulation required to
induce acetylcholine-mediated LTD, there is no requirement for ac-
tivation of NMDA receptors.
Discussion
Glutamate receptors are involved in the induction of synaptic
plasticity in different brain regions (Bliss and Collingridge, 1993;
Bear and Abraham, 1996; Bilkey, 1996; McCaffery et al., 1999;
Ziakopoulos et al., 1999; Cho et al., 2000), but it is unclear how
other neurotransmitter systems modulate synaptic plasticity in
the CNS. We now demonstrate that pharmacological activation of
acetylcholine receptors induces LTD in the
mPFC. Crucially, we demonstrate induc-
tion of activity-dependent LTD that relies
solely on endogenous acetylcholine. This
form of synaptic plasticity may underlie the
mAChR role in prefrontal cortex-
dependent learning and memory (Barker
and Warburton, 2009). Moreover, deficits
in associative memory in Alzheimer’s de-
mentia may result from impaired synaptic
plasticity in mPFC following loss of cholin-
ergic innervation.
Agonist-induced LTD
The induction of LTD by the acetylcho-
line agonist carbachol was not prevented
by NMDAR or mGluR antagonism, indi-
cating that these receptors are not re-
quired for carbachol-mediated LTD.
Furthermore, carbachol-LTD was in-
duced in the absence of synaptic stimu-
lation. Thus, acute activation of
mAChRs alone produces a long-lasting
depression of synaptic transmission in
mPFC (Wang andYuan, 2009;Huang and
Hsu, 2010) and in other cortical regions,
including perirhinal (Massey et al., 2001)
and visual (McCoy and McMahon, 2007)
cortices.
Carbachol-LTD was reduced by inhi-
bition of M1 receptors by pirenzepine or
VU0255035 and mimicked by the M1
agonistsMcN-A-343 or AF102B. Interest-
ingly, the M1 agonists produced a slow-
onset depression without significant
transient LTD. Furthermore, the presence
of theM1 antagonists prevented sustained
LTD and had little effect on transient
LTD. In other experiments, LTD was in-
duced by a subthreshold concentration of
carbachol in the presence of theM1poten-
tiator BQCA that increases affinity of the
receptor to M1 ligands (Ma et al., 2009;
Shirey et al., 2009). Together, the results
with pirenzepine, VU0255035,MCN-A-343, AF102B, andBQCA
suggest that M1 receptor activation underlies induction of sus-
tained LTD in mPFC. In further support of the hypothesis that
the transient and sustained phases of carbachol-LTD are medi-
ated by different mechanisms we found that the early, but not
late, stages of depression were associated with changes in presyn-
aptic glutamate release, as indicated by changes in paired-pulse
facilitation and coefficient of variation. This is in keeping with
previous reports (McCoy andMcMahon, 2007; Huang and Hsu,
2010). Our results also showed that EPSC decay kinetics were
stable during experiments with carbachol. Thus, while sLTD is
most likely a postsynaptic phenomenon, it is unlikely that the
expression of carbachol-LTD is associated with changes in the
subunit composition of AMPA receptors.
Muscarinic M1 receptors couple to phospholipase C, which
results in the production of diacylglycerol and an upregulation
of PKC (Levey, 1996; Eglen, 2006). In keeping with this
(Huang and Hsu, 2010) we found that inhibition of PKC pre-
vented carbachol-LTD. Interestingly, bath applied or postsynap-
Figure 8. An alternative subthreshold LFS protocol can bemade to induce LTDwhen pairedwith bath application of physostig-
mine or BQCA. The delivery of 450 single-pulses to the superficial layers at 1 Hz typically fails to induce LTD in the prelimbic region
(A1, filled circles; A2, ns, not significant). However, continuous application of the acetylcholinesterase inhibitor physostigmine (2
M) converts the subthreshold LFS protocol into one which induces significant LTD (B1, filled circles; B2, *p 0.05). In addition,
increasing the sensitivity of M1 receptors to acetylcholine with BQCA also facilitates induction of LTD in response to subthreshold
LFS (C1, filled circles; C2, *p 0.05).
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tically delivered PKC inhibitors prevented sLTD, with no effect
on tLTD. This suggests that M1 receptors couple to PKC to in-
duce sLTD but that an M1 and PKC-independent mechanism is
responsible for tLTD. Activation of phospholipase C can also
increase inositol triphosphate turnover and, hence, release cal-
cium from intracellular stores. However, in contrast to Huang
and Hsu (2010) and McCoy et al. (2007), we found no evidence
that an increase in intracellular calcium or nitric oxide (Huang
and Hsu, 2010) is required for carbachol-LTD. We reported
previously, however, that application of carbachol induces
LTD in perirhinal cortex that depends on calcium release from
intracellular stores (Massey et al., 2001). The reasons for such
marked discrepancies between studies are not clear, but it is likely
that under different conditions (Huang and Hsu, 2010) and in
different brain regions (Kirkwood et al., 1999; Massey et al., 2001;
McCoy andMcMahon, 2007), different intracellular cascadesmedi-
ate acetylcholine-induced synaptic plasticity.
Activity-dependent LTD
Interestingly, we found that weak stimulation protocols (300
stimulus-pairs at 1 Hz or 450 single-pulses at 1 Hz) subthreshold
for inducing LTD can induce a lasting depression if levels of
acetylcholine are increased by blocking acetylcholinesterase or if
delivered with BQCA (Ma et al., 2009; Shirey et al., 2009). This
facilitation of activity-dependent LTD parallels results showing
that a subthreshold concentration of carbachol induces LTD in
the presence of BQCA. The enhancement of LTD by BQCA was
blocked by mAChR antagonism, illustrating that mAChRs are
involved in activity-dependent LTD. It has been shown previ-
ously that BQCA enhances M1 receptor-dependent calcium rises
in cell lines, muscarinic currents in prefrontal cortex, and c-fos
activation in vivo (Ma et al., 2009; Shirey et al., 2009). However,
our results are the first to demonstrate a facilitatory role of BQCA
in either carbachol-mediated or activity-dependent synaptic
plasticity.
To increase the effects of endogenous acetylcholine without
pharmacological manipulation we increased the intensity of the
stimulus protocol to 450 pulse-pairs (also delivered at 1 Hz) and
found that this produced robust LTD that was blocked by the
mAChR antagonist scopolamine or by the M1-selective antago-
nist VU0255035. These results suggest that the 450 PP-LFS pro-
Figure 9. Increasing the number of stimulation pulse-pairs from 300 to 450 during PP-LFS enhances release of acetylcholine to levels sufficient to induce M1 receptor-dependent LTD in the
prelimbic region.A, The delivery of 450 pairs of stimulation pulses (50ms interpulse interval) at a frequency of 1 Hz induces LTD in themPFC. Induction of this LTD is not blocked by loading cells with
the NMDA receptor channel blocker MK-801 (3 mM; B) or the calcium chelator BAPTA (10 mM; C). Interestingly, however, constant perfusion with the PKC inhibitor Ro-31-8220 (2.5M) blocked
induction of LTD (D). E, The depression of EPSCs induced by 450 PP-LFS was blocked by scopolamine (10M), indicating a critical role for muscarinic receptors. Additionally, induction of LTD was
blocked by VU0255035 (10M; F ) suggesting that this form of activity-dependent depression is mediated, specifically, by activation of M1 receptors. Note that the pharmacology for this form of
activity-dependent LTD mirrors that observed for experiments assessing the effects of carbachol alone on basal synaptic transmission in the prelimbic region.
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tocol leads to sufficient endogenous acetylcholine release and
sufficient activation of M1 mAChRs to induce LTD. In keeping
with the intracellular cascades triggered by mAChRs, LTD in-
duced by the 450 PP-LFS protocol was blocked by inhibition of
PKC. Moreover, this form of LTD did not require NMDAR acti-
vation or an increase in postsynaptic calcium. These results pro-
vide further evidence that activation of mAChRs alone, by
endogenous acetylcholine, is sufficient to induce LTD.Moreover,
these findings provide insight into the potential importance of
acetylcholine in LTD in mPFC. The consequences for mPFC cir-
cuitry of homosynaptic LTD is not known but several scenarios
may exist. Lasting changes in neuronal output related to induc-
tion of LTD inmPFCmight alter the balance of excitation within
and between cortical layers to help encode new information
and/or alter mPFC output to modulate behavior. Alternatively,
although homosynaptic LTD may help form new associations,
large-scale network changes in mPFC might be minimized by
homeostatic regulation of plasticity at other synapses.
The relationship between the various forms of LTD that exist
in mPFC and other brain regions is not clear. Previous reports
have shown that endogenous acetylcholine can either modulate
levels of synaptic plasticity or play a cooperative role with other
receptors, such as NMDARs and mGluRs, so that LTD relies on
activation of a combination of receptors (Kirkwood et al., 1999;
Huber et al., 2001; Huang and Hsu, 2010). In contrast, very few
reports show that a muscarinic antagonist alone can block
activity-dependent LTD (Bonsi et al., 2008). Our results indicate
that activation of mAChRs, by endogenous acetylcholine, is suf-
ficient to induce LTD in mPFC. The reasons why mAChRs alone
induce LTD or why, under certain circumstances, recruitment of
additional receptors is required, may reflect the intensity of the
induction protocols used: intense protocols may produce LTD
that relies on several different receptors (Huber et al., 2001; Volk
et al., 2007) while modest protocols producemAChR-dependent
LTD (our current results). The relevance of LTD for learning has
been described in other studies (Griffiths et al., 2008) and
muscarinic-LTDmay play a critical role in associative learning in
mPFC (Barker andWarburton, 2009). However, it is equally pos-
sible that other forms of LTD may be more relevant for different
types of learning in other brain regions.
Muscarinic receptors inmPFC are required to formobject-in-
place associations (Barker and Warburton, 2009). Additionally,
M1 receptor knock-out mice show deficits in associative memory
that require interactions between cortex and hippocampus (An-
agnostaras et al., 2003). It is tempting to speculate that the plas-
ticity induced by the 450 PP-LFS protocol described here might
be important in mPFC associative memory. Forebrain cholin-
ergic inputs to prefrontal cortex are important for associative
learning (Ross et al., 2005; Barker andWarburton, 2009) and are
tonically active during the awake state. It is possible that tonic
cholinergic innervationmaintainsmPFCnetworks in a “primed”
state so that brief periods of activity related to learning (akin to
the subthreshold protocols in our study) are then sufficient to
induce LTD. Indeed, lesions of basal forebrain nuclei produce
deficits in learning, and a degeneration of cholinergic neurons is
associated with age-dependent cognitive decline and Alzheimer’s
disease (Levey, 1996). Acetylcholinesterase inhibitors are the
most widely used medication to treat individuals with Alzhei-
mer’s dementia and the enhancement of synaptic plasticity by
acetylcholinesterase inhibition that we now demonstrate may be
a way in which these drugs provide clinical efficacy. BQCA has
been shown to reverse learning deficits in mouse models of Alz-
heimer’s disease (Shirey et al., 2009) but the mechanism of this
reversal is not known. Our data suggest that the enhancement of
synaptic plasticity by BQCA might provide the mechanism of
enhanced learning. It would be interesting in the future to deter-
mine whether synaptic plasticity in mPFC is affected in Alzhei-
mer’s disease and whether any plasticity deficits can be reversed
byM1-selective positive allosteric modulators or by acetylcholin-
esterase inhibitors.
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